In addition, ~100% of female Pten+/− mice show extensive lymphadenopathy by 20 weeks, due to impaired Fas-mediated apoptosis of T and B cells, leading to ethical endpoint at ~12 months33. The gene discussed is PTEN; the disease is Lymphadenopathy.